Lupin Pharmaceuticals Inc. is recalling approximately 87,562 units of My Way (levonorgestrel) 1.5 mg emergency contraceptive tablets. The recall was initiated because the specific two-pack carton configuration was released to the market without the required regulatory approval from the FDA. This voluntary action involves products distributed nationwide across the United States in various lot numbers with expiration dates in 2018 and 2019.
The product itself meets quality standards, but the two-pack packaging setup did not receive the necessary FDA approval before being sold. Using a drug product in a configuration not approved by regulatory agencies can lead to inconsistencies in patient labeling or instructions for use.
Contact healthcare provider or return to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.